SCHEMBL13824501

SCHEMBL13824501

C=C(C)C(=C\C=C/N)/C(=C\CCN(CC)CCN(CC)c1ccc(Cl)cc1)c1cc(C(C)(C)O)ccc1O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14579592 0.66 CCR1 (0.35) —
SCHEMBL10893564 0.59 CNR2 (0.49) —
SCHEMBL10889974 0.53 KCNH2 (0.46) —
SCHEMBL8746233 0.52 CNR2 (0.53) —
SCHEMBL14596279 0.52 ALDH1A1 (0.69) —
SCHEMBL2881066 0.51 CNR2 (0.63) —
SCHEMBL10148475 0.50 PTGS2 (0.35) —
SCHEMBL1016971 0.50 KMT2A (0.71) —
SCHEMBL15984367 0.49 ALDH1A1 (0.50) —
SCHEMBL11699940 0.49 HSD17B10 (0.48) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7541365-B2 Chemokine receptor antagonists and methods of use therefor MILLENNIUM PHARMACEUTICALS, INC. (US) 2009-06-02 — — US disclosed
Send feedback